One-year data suggest allogeneic stem cell-derived islet-cell therapy could become a future option for those with type 1 ...

Novo Nordisk rebounds from 2024 lows as GLP-1 supply issues ease, partnerships expand, and valuation turns attractive. Find ...

An obesity drug from China helped patients lose a lot of weight in a late-stage clinical trial, making it a prospective new ...

An intervention designed to emphasize management of overweight and obesity in primary care settings was associated with ...

New data from a Phase 3 trial show that the daily anti-obesity pill may be as safe and effective as drugs like Mounjaro and ...

A new generation of weight-loss drugs has proven remarkably effective, hugely popular and massively lucrative in the last few ...

Eli Lilly & Co.’s experimental weight-loss pill helped patients shed pounds without serious side effects in a clinical trial, burnishing the drug’s blockbuster potential in the company’s competition ...

A new generation of weight-loss drugs has proven remarkably effective, hugely popular and massively lucrative in the last few ...

A protocol designed for primary care increased weight loss across a quarter of a million people, but only 25% of those with a ...

This would make amycretin a more effective than other weight loss drugs like Wegovy, where a trial found that patients lost ...

A new weight loss medication, which can be offered by injection or tablet, can help patients lose a significant amount weight ...

A new weight loss treatment that can be taken as either a daily pill or a weekly injection has shown very promising results ...